Basel, 28 February 2019 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Herceptin Hylecta(TM) (trastuzumab and hyaluronidase-oysk) for ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Among the top stories in ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) has approved Herceptin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback